XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.1
UNAUDITED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Balance, beginning of period at Dec. 31, 2023 $ 651,202 $ 0 $ 167 $ 162,386 $ (3,880) $ 492,529
Balance, beginning of period (in shares) at Dec. 31, 2023     16,684,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 18,939         18,939
Stock issued under compensation plans, net (in shares)     114,000      
Stock issued under compensation plans, net 0   $ 1 (1)    
Stock-based compensation expense $ 1,917     1,917    
Shares repurchased related to tax withholding for stock-based compensation (in shares) (36,397)   (36,000)      
Shares repurchased related to tax withholding for stock-based compensation $ (5,866)   $ (1) (5,511)   (354)
Other comprehensive income (loss) (2,472)       (2,472)  
Balance, end of period at Mar. 31, 2024 663,720 0 $ 167 158,791 (6,352) 511,114
Balance, end of period (in shares) at Mar. 31, 2024     16,762,000      
Balance, beginning of period at Dec. 31, 2024 600,360 0 $ 161 159,133 (12,651) 453,717
Balance, beginning of period (in shares) at Dec. 31, 2024     16,122,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 23,308         23,308
Stock issued under compensation plans, net (in shares)     58,000      
Stock issued under compensation plans, net 0   $ 1 (1)    
Stock-based compensation expense $ 2,333     2,333    
Shares repurchased related to tax withholding for stock-based compensation (in shares) (18,866)   (19,000)      
Shares repurchased related to tax withholding for stock-based compensation $ (2,451)   $ (1) (2,264)   (186)
Share repurchases under share repurchase program $ (75,000)   $ (6) (6,303)   (68,691)
Share repurchases under share repurchase program (in shares) (639,207)   (639,000)      
Other comprehensive income (loss) $ 122       122  
Balance, end of period at Mar. 31, 2025 $ 548,672 $ 0 $ 155 $ 152,898 $ (12,529) $ 408,148
Balance, end of period (in shares) at Mar. 31, 2025     15,522,000